APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Icatibant Acetate Injection

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Icatibant Acetate Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174001350328 December 2025184 pages

Choose your research edition.

Industry ResearchIcatibant Acetate Injection Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Icatibant Acetate Injection Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Icatibant Acetate Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Icatibant Acetate Injection Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Icatibant Acetate Injection Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Icatibant Acetate Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Icatibant Acetate Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Icatibant Acetate Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Icatibant Acetate Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Icatibant Acetate Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Icatibant Acetate Injection include Cipla, Eugia Pharma Specialities, Fresenius Kabi, Glenmark Pharmaceuticals, Chengdu Shengnuo Biology Pharmacy, Jiangsu Hengrui Pharmaceuticals, Sandoz and Takeda Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Icatibant Acetate Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Icatibant Acetate Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Icatibant Acetate Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Icatibant Acetate Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Icatibant Acetate Injection Segment by Company

Cipla

Eugia Pharma Specialities

Fresenius Kabi

Glenmark Pharmaceuticals

Chengdu Shengnuo Biology Pharmacy

Jiangsu Hengrui Pharmaceuticals

Sandoz

Takeda Pharmaceuticals

Icatibant Acetate Injection Segment by Type

Original Drug

Generic Drug

Icatibant Acetate Injection Segment by Application

Hospital and Clinic

Pharmacy

Other

Icatibant Acetate Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Icatibant Acetate Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Icatibant Acetate Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Icatibant Acetate Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Icatibant Acetate Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Icatibant Acetate Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Icatibant Acetate Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Icatibant Acetate Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Icatibant Acetate Injection Industry Trends Table 2. Icatibant Acetate Injection Industry Drivers Table 3. Icatibant Acetate Injection Industry Opportunities and Challenges Table 4. Icatibant Acetate Injection Industry Restraints Table 5. Global Icatibant Acetate Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Icatibant Acetate Injection Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Icatibant Acetate Injection Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Icatibant Acetate Injection Sales Market Share by Manufacturers Table 9. Global Icatibant Acetate Injection Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Icatibant Acetate Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Icatibant Acetate Injection Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Icatibant Acetate Injection Manufacturers, Product Type & Application Table 13. Global Icatibant Acetate Injection Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Icatibant Acetate Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Original Drug Table 17. Major Manufacturers of Generic Drug Table 18. Global Icatibant Acetate Injection Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Icatibant Acetate Injection Sales by Type (2021-2026) & (K Units) Table 20. Global Icatibant Acetate Injection Sales by Type (2027-2032) & (K Units) Table 21. Global Icatibant Acetate Injection Sales Market Share by Type (2021-2026) Table 22. Global Icatibant Acetate Injection Sales Market Share by Type (2027-2032) Table 23. Global Icatibant Acetate Injection Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Icatibant Acetate Injection Revenue by Type (2021-2026) & (K Units) Table 25. Global Icatibant Acetate Injection Revenue by Type (2027-2032) & (K Units) Table 26. Global Icatibant Acetate Injection Revenue Market Share by Type (2021-2026) Table 27. Global Icatibant Acetate Injection Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital and Clinic Table 29. Major Manufacturers of Pharmacy Table 30. Major Manufacturers of Other Table 31. Global Icatibant Acetate Injection Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Icatibant Acetate Injection Sales by Application (2021-2026) & (K Units) Table 33. Global Icatibant Acetate Injection Sales by Application (2027-2032) & (K Units) Table 34. Global Icatibant Acetate Injection Sales Market Share by Application (2021-2026) Table 35. Global Icatibant Acetate Injection Sales Market Share by Application (2027-2032) Table 36. Global Icatibant Acetate Injection Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Icatibant Acetate Injection Revenue by Application (2021-2026) & (K Units) Table 38. Global Icatibant Acetate Injection Revenue by Application (2027-2032) & (K Units) Table 39. Global Icatibant Acetate Injection Revenue Market Share by Application (2021-2026) Table 40. Global Icatibant Acetate Injection Revenue Market Share by Application (2027-2032) Table 41. Global Icatibant Acetate Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Icatibant Acetate Injection Sales by Region (2021-2026) & (K Units) Table 43. Global Icatibant Acetate Injection Sales Market Share by Region (2021-2026) Table 44. Global Icatibant Acetate Injection Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Icatibant Acetate Injection Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Icatibant Acetate Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Icatibant Acetate Injection Sales by Country (2021-2026) & (K Units) Table 48. North America Icatibant Acetate Injection Sales by Country (2027-2032) & (K Units) Table 49. Europe Icatibant Acetate Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Icatibant Acetate Injection Sales by Country (2021-2026) & (K Units) Table 51. Europe Icatibant Acetate Injection Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Icatibant Acetate Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Icatibant Acetate Injection Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Icatibant Acetate Injection Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Icatibant Acetate Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Icatibant Acetate Injection Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Icatibant Acetate Injection Sales by Country (2027-2032) & (K Units) Table 58. Global Icatibant Acetate Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Icatibant Acetate Injection Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Icatibant Acetate Injection Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Icatibant Acetate Injection Revenue Market Share by Region (2021-2026) Table 62. Global Icatibant Acetate Injection Revenue Market Share by Region (2027-2032) Table 63. Cipla Company Information Table 64. Cipla Business Overview Table 65. Cipla Icatibant Acetate Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Cipla Icatibant Acetate Injection Product Portfolio Table 67. Cipla Recent Development Table 68. Eugia Pharma Specialities Company Information Table 69. Eugia Pharma Specialities Business Overview Table 70. Eugia Pharma Specialities Icatibant Acetate Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Eugia Pharma Specialities Icatibant Acetate Injection Product Portfolio Table 72. Eugia Pharma Specialities Recent Development Table 73. Fresenius Kabi Company Information Table 74. Fresenius Kabi Business Overview Table 75. Fresenius Kabi Icatibant Acetate Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Fresenius Kabi Icatibant Acetate Injection Product Portfolio Table 77. Fresenius Kabi Recent Development Table 78. Glenmark Pharmaceuticals Company Information Table 79. Glenmark Pharmaceuticals Business Overview Table 80. Glenmark Pharmaceuticals Icatibant Acetate Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Glenmark Pharmaceuticals Icatibant Acetate Injection Product Portfolio Table 82. Glenmark Pharmaceuticals Recent Development Table 83. Chengdu Shengnuo Biology Pharmacy Company Information Table 84. Chengdu Shengnuo Biology Pharmacy Business Overview Table 85. Chengdu Shengnuo Biology Pharmacy Icatibant Acetate Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Chengdu Shengnuo Biology Pharmacy Icatibant Acetate Injection Product Portfolio Table 87. Chengdu Shengnuo Biology Pharmacy Recent Development Table 88. Jiangsu Hengrui Pharmaceuticals Company Information Table 89. Jiangsu Hengrui Pharmaceuticals Business Overview Table 90. Jiangsu Hengrui Pharmaceuticals Icatibant Acetate Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Jiangsu Hengrui Pharmaceuticals Icatibant Acetate Injection Product Portfolio Table 92. Jiangsu Hengrui Pharmaceuticals Recent Development Table 93. Sandoz Company Information Table 94. Sandoz Business Overview Table 95. Sandoz Icatibant Acetate Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Sandoz Icatibant Acetate Injection Product Portfolio Table 97. Sandoz Recent Development Table 98. Takeda Pharmaceuticals Company Information Table 99. Takeda Pharmaceuticals Business Overview Table 100. Takeda Pharmaceuticals Icatibant Acetate Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Takeda Pharmaceuticals Icatibant Acetate Injection Product Portfolio Table 102. Takeda Pharmaceuticals Recent Development Table 103. Key Raw Materials Table 104. Raw Materials Key Suppliers Table 105. Icatibant Acetate Injection Distributors List Table 106. Icatibant Acetate Injection Customers List Table 107. Research Programs/Design for This Report Table 108. Authors List of This Report Table 109. Secondary Sources Table 110. Primary Sources List of Figures Figure 1. Icatibant Acetate Injection Product Image Figure 2. Global Icatibant Acetate Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Icatibant Acetate Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Icatibant Acetate Injection Sales (2021-2032) & (K Units) Figure 5. Global Icatibant Acetate Injection Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Icatibant Acetate Injection Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Original Drug Image Figure 9. Generic Drug Image Figure 10. Global Icatibant Acetate Injection Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Icatibant Acetate Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Icatibant Acetate Injection Sales Market Share by Type (2021-2032) Figure 13. Global Icatibant Acetate Injection Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Icatibant Acetate Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Icatibant Acetate Injection Revenue Market Share by Type (2021-2032) Figure 16. Hospital and Clinic Image Figure 17. Pharmacy Image Figure 18. Other Image Figure 19. Global Icatibant Acetate Injection Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Icatibant Acetate Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Icatibant Acetate Injection Sales Market Share by Application (2021-2032) Figure 22. Global Icatibant Acetate Injection Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Icatibant Acetate Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Icatibant Acetate Injection Revenue Market Share by Application (2021-2032) Figure 25. North America Icatibant Acetate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Icatibant Acetate Injection Sales Market Share by Country (2021-2032) Figure 27. U.S. Icatibant Acetate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Icatibant Acetate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Icatibant Acetate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Icatibant Acetate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Icatibant Acetate Injection Sales Market Share by Country (2021-2032) Figure 32. Germany Icatibant Acetate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Icatibant Acetate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Icatibant Acetate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Icatibant Acetate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Icatibant Acetate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Icatibant Acetate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Icatibant Acetate Injection Sales Market Share by Country (2021-2032) Figure 39. China Icatibant Acetate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Icatibant Acetate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Icatibant Acetate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Icatibant Acetate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Icatibant Acetate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Icatibant Acetate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Icatibant Acetate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Icatibant Acetate Injection Sales Market Share by Country (2021-2032) Figure 47. Brazil Icatibant Acetate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Icatibant Acetate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Icatibant Acetate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Icatibant Acetate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Icatibant Acetate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Icatibant Acetate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Icatibant Acetate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Icatibant Acetate Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Icatibant Acetate Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Icatibant Acetate Injection Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Icatibant Acetate Injection Revenue (2021-2032) & (US$ Million) Figure 58. North America Icatibant Acetate Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Icatibant Acetate Injection Revenue (2021-2032) & (US$ Million) Figure 60. Europe Icatibant Acetate Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Icatibant Acetate Injection Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Icatibant Acetate Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Icatibant Acetate Injection Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Icatibant Acetate Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Icatibant Acetate Injection Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Icatibant Acetate Injection Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Original Drug
  • Generic Drug
Applications
  • Hospital and Clinic
  • Pharmacy
  • Other
Companies covered
  • Cipla
  • Eugia Pharma Specialities
  • Fresenius Kabi
  • Glenmark Pharmaceuticals
  • Chengdu Shengnuo Biology Pharmacy
  • Jiangsu Hengrui Pharmaceuticals
  • Sandoz
  • Takeda Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Icatibant Acetate Injection Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Icatibant Acetate Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Icatibant Acetate Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Icatibant Acetate Injection Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Icatibant Acetate Injection Market Dynamics
  1. 2.1 Icatibant Acetate Injection Industry Trends
  2. 2.2 Icatibant Acetate Injection Industry Drivers
  3. 2.3 Icatibant Acetate Injection Industry Opportunities and Challenges
  4. 2.4 Icatibant Acetate Injection Industry Restraints
3 Icatibant Acetate Injection Market by Manufacturers
  1. 3.1 Global Icatibant Acetate Injection Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Icatibant Acetate Injection Sales by Manufacturers (2021-2026)
  3. 3.3 Global Icatibant Acetate Injection Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Icatibant Acetate Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Icatibant Acetate Injection Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Icatibant Acetate Injection Manufacturers, Product Type & Application
  7. 3.7 Global Icatibant Acetate Injection Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Icatibant Acetate Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Icatibant Acetate Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Icatibant Acetate Injection Tier 1, Tier 2, and Tier 3
4 Icatibant Acetate Injection Market by Type
  1. 4.1 Icatibant Acetate Injection Type Introduction
  2. 4.1.1 Original Drug
  3. 4.1.2 Generic Drug
  4. 4.2 Global Icatibant Acetate Injection Sales by Type
  5. 4.2.1 Global Icatibant Acetate Injection Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Icatibant Acetate Injection Sales by Type (2021-2032)
  7. 4.2.3 Global Icatibant Acetate Injection Sales Market Share by Type (2021-2032)
  8. 4.3 Global Icatibant Acetate Injection Revenue by Type
  9. 4.3.1 Global Icatibant Acetate Injection Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Icatibant Acetate Injection Revenue by Type (2021-2032)
  11. 4.3.3 Global Icatibant Acetate Injection Revenue Market Share by Type (2021-2032)
5 Icatibant Acetate Injection Market by Application
  1. 5.1 Icatibant Acetate Injection Application Introduction
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Pharmacy
  4. 5.1.3 Other
  5. 5.2 Global Icatibant Acetate Injection Sales by Application
  6. 5.2.1 Global Icatibant Acetate Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Icatibant Acetate Injection Sales by Application (2021-2032)
  8. 5.2.3 Global Icatibant Acetate Injection Sales Market Share by Application (2021-2032)
  9. 5.3 Global Icatibant Acetate Injection Revenue by Application
  10. 5.3.1 Global Icatibant Acetate Injection Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Icatibant Acetate Injection Revenue by Application (2021-2032)
  12. 5.3.3 Global Icatibant Acetate Injection Revenue Market Share by Application (2021-2032)
6 Global Icatibant Acetate Injection Sales by Region
  1. 6.1 Global Icatibant Acetate Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Icatibant Acetate Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Icatibant Acetate Injection Sales by Region (2021-2026)
  4. 6.2.2 Global Icatibant Acetate Injection Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Icatibant Acetate Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Icatibant Acetate Injection Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Icatibant Acetate Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Icatibant Acetate Injection Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Icatibant Acetate Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Icatibant Acetate Injection Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Icatibant Acetate Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Icatibant Acetate Injection Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Icatibant Acetate Injection Revenue by Region
  1. 7.1 Global Icatibant Acetate Injection Revenue by Region
  2. 7.1.1 Global Icatibant Acetate Injection Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Icatibant Acetate Injection Revenue by Region (2021-2026)
  4. 7.1.3 Global Icatibant Acetate Injection Revenue by Region (2027-2032)
  5. 7.1.4 Global Icatibant Acetate Injection Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Icatibant Acetate Injection Revenue (2021-2032)
  8. 7.2.2 North America Icatibant Acetate Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Icatibant Acetate Injection Revenue (2021-2032)
  11. 7.3.2 Europe Icatibant Acetate Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Icatibant Acetate Injection Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Icatibant Acetate Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Icatibant Acetate Injection Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Icatibant Acetate Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Cipla
  2. 8.1.1 Cipla Company Information
  3. 8.1.2 Cipla Business Overview
  4. 8.1.3 Cipla Icatibant Acetate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Cipla Icatibant Acetate Injection Product Portfolio
  6. 8.1.5 Cipla Recent Developments
  7. 8.2 Eugia Pharma Specialities
  8. 8.2.1 Eugia Pharma Specialities Company Information
  9. 8.2.2 Eugia Pharma Specialities Business Overview
  10. 8.2.3 Eugia Pharma Specialities Icatibant Acetate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Eugia Pharma Specialities Icatibant Acetate Injection Product Portfolio
  12. 8.2.5 Eugia Pharma Specialities Recent Developments
  13. 8.3 Fresenius Kabi
  14. 8.3.1 Fresenius Kabi Company Information
  15. 8.3.2 Fresenius Kabi Business Overview
  16. 8.3.3 Fresenius Kabi Icatibant Acetate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Fresenius Kabi Icatibant Acetate Injection Product Portfolio
  18. 8.3.5 Fresenius Kabi Recent Developments
  19. 8.4 Glenmark Pharmaceuticals
  20. 8.4.1 Glenmark Pharmaceuticals Company Information
  21. 8.4.2 Glenmark Pharmaceuticals Business Overview
  22. 8.4.3 Glenmark Pharmaceuticals Icatibant Acetate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Glenmark Pharmaceuticals Icatibant Acetate Injection Product Portfolio
  24. 8.4.5 Glenmark Pharmaceuticals Recent Developments
  25. 8.5 Chengdu Shengnuo Biology Pharmacy
  26. 8.5.1 Chengdu Shengnuo Biology Pharmacy Company Information
  27. 8.5.2 Chengdu Shengnuo Biology Pharmacy Business Overview
  28. 8.5.3 Chengdu Shengnuo Biology Pharmacy Icatibant Acetate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Chengdu Shengnuo Biology Pharmacy Icatibant Acetate Injection Product Portfolio
  30. 8.5.5 Chengdu Shengnuo Biology Pharmacy Recent Developments
  31. 8.6 Jiangsu Hengrui Pharmaceuticals
  32. 8.6.1 Jiangsu Hengrui Pharmaceuticals Company Information
  33. 8.6.2 Jiangsu Hengrui Pharmaceuticals Business Overview
  34. 8.6.3 Jiangsu Hengrui Pharmaceuticals Icatibant Acetate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Jiangsu Hengrui Pharmaceuticals Icatibant Acetate Injection Product Portfolio
  36. 8.6.5 Jiangsu Hengrui Pharmaceuticals Recent Developments
  37. 8.7 Sandoz
  38. 8.7.1 Sandoz Company Information
  39. 8.7.2 Sandoz Business Overview
  40. 8.7.3 Sandoz Icatibant Acetate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Sandoz Icatibant Acetate Injection Product Portfolio
  42. 8.7.5 Sandoz Recent Developments
  43. 8.8 Takeda Pharmaceuticals
  44. 8.8.1 Takeda Pharmaceuticals Company Information
  45. 8.8.2 Takeda Pharmaceuticals Business Overview
  46. 8.8.3 Takeda Pharmaceuticals Icatibant Acetate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Takeda Pharmaceuticals Icatibant Acetate Injection Product Portfolio
  48. 8.8.5 Takeda Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Icatibant Acetate Injection Value Chain Analysis
  2. 9.1.1 Icatibant Acetate Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Icatibant Acetate Injection Production Mode & Process
  6. 9.2 Icatibant Acetate Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Icatibant Acetate Injection Distributors
  9. 9.2.3 Icatibant Acetate Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst